Fundraising Fox
Boston · Seed–Series B · 6 people tracked
Also known as Solasta · SOLASTA VENTURES, INC.
Find your way into Solasta Ventures
Sign up to see every warm intro you have to Solasta Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solasta Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Solasta Ventures focuses on healthcare and life sciences, investing in companies working to advance medicine. The team brings more than 30 years of combined experience across healthcare investments and drug development, and invites founders whose mission aligns with advancing medicine to connect.
Source: firm website, verified Sep 29, 2026.
Team · 6 people
from the firm's website
What they invest in
from 32 of 38 portfolio companiesBiotech ×25Healthtech ×16Medical Devices ×9Deep Tech ×7AI & Machine Learning ×4Consumer ×3Hardware ×3Digital Health ×2
HQs:United States×27China×1United Kingdom×1
Who they back
founder profiles across 17 portfolio companiesFounding team size:solo founder×92 founders×73 founders×1
What their founders studiedfrom 10 founders with field-of-study data
Life Sciences ×4Medicine ×2Politics & Policy ×2
Where their founders worked beforefrom 14 founders with career history
Atlas Venture ×2
Investments · 38 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 42022 · 42021 · 22020 · 12017 · 12015 · 115 dated
Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.
BiotechHealthtechNew Haven, US
Sean Cassidy(Executive Officer)inManuel Litchman(Executive Officer, Director)inRandy Teel(President and Chief Executive Officer; Director)inCraig Crews(Founder)
BoardStephen Squinto(Director)inLiam Ratcliffe(Director)in
Co-investors5AM VenturesAccess BiotechnologyCanaan PartnersConnecticut InnovationsNextech InvestRA Capital+2 more
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.
BiotechDeep TechHealthtech
Nello Mainolfi(Founder)inBruce Booth(Chair)in
Co-investorsAtlas VentureAvoro Capital AdvisorsBain Capital Life SciencesBessemer Venture PartnersHatteras Venture PartnersMRL Ventures Fund+7 more
Pinterest operates a visual discovery platform where users save and browse images organised into boards, used heavily for shopping, recipes and design.
San Francisco, US
Evan Sharp(Founder)Ben Silbermann(Founder)inPaul Sciarra(Founder)Mike Yang(Executive Officer)Natalie Fair(Executive Officer)inBill Ready(Chief Executive Officer)in
Co-investors3Spoke CapitalA.Capital VenturesA*Acequia Capital (AceCap)Allied Venture PartnersAmakor+64 more
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalMitsui Global InvestmentPivotal Life Sciences+2 more
Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.
BiotechDeep TechHardwareHealthtechBoston, US
Omid Farokhzad(Founder)inPhilip Ma(Executive Officer)Shadi Aryanpour(Executive Officer)David Singer(Director)Omid Cameron Farokhzad(Founder)in
BoardTerrance McGuire(Director)
Co-investorsSoftBank Vision FundWingaMoonMaverick VenturesPolaris PartnersT. Rowe Price
Sutro is a biotech company developing a cell-free protein synthesis platform for the design and manufacturing of complex biologics, particularly cancer therapies and antibody-drug conjugates.
BiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
William J. Newell(Executive Officer, Director)Jane Chung(Chief Executive Officer)inHans-Peter Gerber(Chief Scientific Officer)inDavid Pauling(Chief Administrative Officer and General Counsel)inJonathan Fawcett(VP, Head of Clinical Development)inDevendra Luhar(SVP, Technical Operations)in
Co-investorsOwl CapitalRidgeback CapitalSamsara BioCapitalSV Health InvestorsVida Ventures
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.
BiotechDeep TechMedical DevicesCambridge, US
Bharatt Chowrira(Executive Officer)inMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)inPaul Miller(Executive Officer)inAoife Brennan(Executive Officer)inTodd Shegog(Executive Officer)in
Co-investorsAtlas VentureCLI VenturesNew Enterprise Associates (NEA)NSG VenturesPfizer Venture InvestmentsSofinnova Ventures+1 more
Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.
BiotechHealthtechWaltham, US
René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)
Co-investorsBain Capital Life SciencesBay City CapitalF-Prime CapitalM VenturesMRL Ventures FundRA Capital+9 more
EvolveImmune develops immunotherapy treatments for cancer patients.
BiotechHealthtechMedical DevicesBranford, US
Stephen Bloch(Co-founder and Chief Executive Officer)inDonmienne Leung(Manager)Ian Taylor(Manager)Jay Fine(President, Research and Development)
BoardDerek Yoon(Manager)inJasmina Marjanovic(Manager)in
Co-investorsPfizer VenturesElm Street VenturesPfizer Venture InvestmentsTakeda Ventures
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Co-investorsExSight VenturesHatteras Venture PartnersAccess BiotechnologyBios PartnersCorrelation VenturesFemHealth Ventures+1 more
Clinical-stage immuno-oncology company developing molecules to restore anti-tumor immunity.
Co-investorsKorys
NASDAQ-listed company developing therapies for complement cascade-driven diseases in haematology, ophthalmology, and nephrology.
BiotechCrestwood, US
Pascal Deschatelets(Executive Officer)inCedric Francois(Executive Officer, Director)in
BoardGerald Chan(Director)Stephanie O'Brien(Director)Alec Machiels(Director)A. Sinclair Dunlop(Director)
Co-investorsAvoro Capital AdvisorsEMBL VenturesEpidarex CapitalF-Prime CapitalKeyhorse CapitalSofinnova Ventures+1 more
Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.
BiotechHealthtechGaithersburg, US
Han Lee(Executive Officer)Rami Elghandour(Executive Officer, Director)in
BoardJill Carroll(Director)inAli Behbahani(Director)inDerek Yoon(Director)inTiba Aynechi(Director)in
Co-investorsLG Technology VenturesNew Enterprise Associates (NEA)Quan CapitalSamsara BioCapitalSixty Degree CapitalSR One Capital Management+4 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more
Boxhub operates an online marketplace for buying and selling shipping containers, modernizing the traditionally fragmented container trade through digital technology.
B2B MarketplacesE-commerceLogistics & Supply Chain
Maxmillian Birner(Co-Founder & CEO)Maximilian Birner(Founder)inMax Birner(Founder)Niklas Östberg(Founder)Philip Skov(Founder)
Co-investorsAlleyCorpFJ LabsAlley Robotics VenturesHum CapitalInterplay Ventures Early Stage Management LlcMotion Ventures
The page presents Pinco Casino, an online gambling platform offering slots, live casino, table games, and sports betting with a Turkish-language interface.
ConsumerGamingHealthtechBoston, US
Robert Kotin(Executive Officer, Director)Chen Schor(Director)Robert Hadfield(Executive Officer)John Lawrence(Executive Officer)
BoardGeeta Vemuri(Director)inDerek Yoon(Director)in
Co-investorsAstellas Venture Management LLCDC Investment PartnersUTokyo Innovation Platform Co. Ltd.Agent CapitalLongwood Fund
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)in
BoardMargarita Chavez(Director)inEran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)in
Co-investorsAgent CapitalAju IB InvestmentAnzu PartnersGrazia Equity GmbHHealthCapMRL Ventures Fund+3 more
BiotechBerkeley, US
Genine Winslow(Founder)inRan Geng(Director)Winnie Wan(Director)
Co-investorsBerkeley SkyDeck FundFuture Planet CapitalTachyon Ventures
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Mark Prausnitz(Director)inCharles Deignan(Executive Officer)Glenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Co-investorsHEALTHCARE ROYALTY PARTNERSMountain Group CapitalHatterasHatteras Venture Partners
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB InvestmentCatalio Capital Management, LPDelos CapitalF-Prime CapitalViking Global+10 more
G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.
BiotechResearch Triangle Park, US
Jay Strum(Executive Officer)Norman Sharpless(Director)Mark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)
Co-investorsLumira VenturesMountain Group CapitalRA CapitalHatteras Venture Partners
HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies.
AI & Machine LearningBiotechHealthtech
BoardBruce Booth(Chairman)in
Co-investorsAtlas VentureB Capital GroupB4 CapitalMRL Ventures FundPivotal Life SciencesSofinnova Partners+2 more
.jpeg){kind=logo}
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsAgent CapitalDC Investment PartnersLifelinkLongwood FundMedical Excellence CapitalNovartis Venture Fund+5 more
Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Co-investorsBay City CapitalChiesi VenturesPappas CapitalQiming Venture Partners USACowen Healthcare InvestmentsEcoR1 Capital+1 more
Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs.
BiotechHealthtechCambridge, GB
John McCafferty(Co-founder and CTO)inAneesh Karatt-Vellatt(Co-founder and CSO)inArndt Schottelius, MD, PhD(CEO)
Co-investorsGeneral CatalystLifeArc VenturesMonograph Capital Partners
.png)
Molecular Templates, Inc. was a clinical-stage biopharmaceutical company formerly based in Austin, TX.
BiotechAustin, US
Co-investorsHitecVision Advisory ASLongitude CapitalSofinnova Ventures
Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses.
BiotechDeep TechNewton, US
Nikolai Kley(Founder)inNikolai Kley, Ph.D.(Executive Officer, Director)
BoardGriet Vanpoucke, Ph.D.(Director)Steven R. Gullans, Ph.D.(Director)
Co-investorsEmpire AngelsExcel Venture ManagementSolari CapitalV-Bio VenturesWessel Management
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)inJoshua Nixon(Founder)
Co-investorsAlumni VenturesCollaborative FundDiamond Edge VenturesDnx VenturesPangaea Ventures Us Inc.Portfolia+9 more
RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases.
BiotechHealthtech
Co-investorsForesite CapitalFrazier Life SciencesGV (Google Ventures)Kleiner PerkinsMedicxiThe Column Group+1 more
ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)
Co-investorsAju IB InvestmentEcoR1 CapitalEvolution VC PartnersMPM BioImpactOrbiMedOUP (Osage University Partners)+6 more
Soul is a Chinese AI-powered immersive social platform where users interact through customizable avatars rather than real identities, matched by interest graphs and AI-driven recommendations.
AI & Machine LearningConsumerSocialShanghai, CN
Zhang Lu(CEO & Founder)Tao Ming(Chief Technology Officer & Executive Director)Zhang Gaozheng(Vice President of Technology & Executive Director)
Co-investors5Y CapitalGranite AsiaVentekCleveland AvenueHorizons VenturesLiberty City Ventures+2 more
Soul Machines develops "Experiential AI" technology to create lifelike, human-like Digital Workers that can see, hear, react, remember and respond emotionally, using cognitive modeling and a patented Digital Brain.
AI & Machine LearningDeep TechEnterprise SoftwareSaaS
Greg Cross(Founder)Mark Sagar(Founder)Julie Kim(Chief Executive Officer)Ali Roberts(Chief Financial Officer)inShane Blackett(Chief Technology Officer)inDarren Wilson(Chief Product Officer)
Co-investorsBright Pixel CapitalCleveland AvenueSoftBank Vision FundHorizons VenturesICONIQ CapitalLakestar+3 more
Summer Robotics builds laser-event sensing technology, a camera-free perception system that lets industrial robots recognize, track, measure, and adapt to parts in real time with 100-micron precision and fast reaction times.
Advanced ManufacturingHardwareRoboticsCampbell, US
Gerard Dirk Smits(Director)Schuyler Alexander Cullen(Executive Officer, Director)
Co-investorsAju IB InvestmentNaver D2SFSeabed VCApplied VenturesNaver
Wearlinq develops the eWave, a wireless, FDA-cleared 6-lead continuous ECG cardiac monitor with a patient smartphone app and the LiveLinq platform for clinicians to review ECG waveforms and reports.
Digital HealthHardwareMedical DevicesSan Francisco, US
Michael Torres(Executive Officer)inChris Daniel(Executive Officer)inYuxin Liu(Executive Officer, Director)Konrad Morzkowski(Executive Officer, Director)
BoardKrish W. Ramadurai(Director)inJoseph Knight(Director)
Co-investorsAIX VenturesAju IB InvestmentAlumni VenturesAmino CapitalCeltic House Asia PartnersDevice of Tomorrow Capital+7 more
-2.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BellicumRally BiotherapeuticsSelecta BiosciencesTibit Communications
Exits · 10
8 IPOs · 2 acquisitionsArvinas Holding Co. LLCNASDAQ: ARVNKymera TherapeuticsNASDAQ: KYMRPinterestNYSE: PINSRallybio, LLCNASDAQ: RLYBSeerNASDAQ: SEERSutrobioNASDAQ: STROSynlogicOTC: SYBXXilio TherapeuticsNASDAQ: XLOApellis Pharmaceuticalsacq. by BiogenRAPT Therapeuticsacq. by GSK
Portfolio news
latest coverage across their companiesWearlinq · finsmes.com · Dec 18, 2025
Summer Robotics · finsmes.com · Oct 1, 2025
Ensoma · finsmes.com · Sep 23, 2025
Frequently asked questions
- How many investments has Solasta Ventures made?
- Solasta Ventures has 38 tracked investments, 10 of which have exited, including 2 dated in the last 24 months.
- What stage does Solasta Ventures invest at?
- Solasta Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Solasta Ventures focus on?
- Solasta Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Solasta Ventures located?
- Solasta Ventures is headquartered in Boston, US.
- Who does Solasta Ventures co-invest with?
- Solasta Ventures most often shares deals with F-Prime Capital, MRL Ventures Fund, Pfizer Venture Investments, among 99 tracked co-investors.
Co-investors · 3
Intel Capital is the corporate venture capital arm of Intel Corporation, investing in AI and deep tech companies across cloud, devices, frontier, and silicon.
Madrona Venture Group is a venture capital firm that backs founding teams at the seed, early, and acceleration stages, with a focus on Seattle, the Bay Area, and beyond.
Propel Venture Partners is an early-stage venture capital firm that backs founders building companies for the new economy.
Firms observed investing alongside Solasta Ventures, from public investor directories. Shared companies are the overlap with Solasta Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.